Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL300412 | 0.95 | ACHE (0.47) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916614 | 0.93 | ACHE (0.47) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916566 | 0.93 | ACHE (0.47) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL16248012 | 0.91 | ACHE (0.44) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL809069 | 0.91 | ACHE (0.61) | ACHE | |
| SCHEMBL27030671 | 0.89 | ACHE (0.46) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916903 | 0.89 | KMT2A (0.42) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL5916494 | 0.89 | ACHE (0.42) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18878216 | 0.88 | ACHE (0.44) | ACHEHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL20544859 | 0.88 | ACHE (0.44) | ACHEHDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 822 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3820876-B1 | PREPARATION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2023-09-06 | — | — | EP | claimed |
| EP-4035649-B1 | DENTAL ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-07-26 | — | — | EP | claimed |
| US-11655263-B2 | Preparation of isocyanatosilanes | MOMENTIVE PERFORMANCE MATERIALS INC (US) | 2023-05-23 | — | — | US | claimed |
| EP-4035649-A1 | DENTAL ADHESIVE COMPOSITION | 3M Innovative Properties Company (US) | 2022-08-03 | — | — | EP | claimed |
| US-20210277035-A1 | PREPARATION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2021-09-09 | — | — | US | claimed |
| EP-3820876-A1 | PREPARATION OF ISOCYANATOSILANES | Momentive Performance Materials Inc. (US) | 2021-05-19 | — | — | EP | claimed |
| CN-112513054-A | Preparation of isocyanatosilanes | 莫门蒂夫性能材料股份有限公司 | 2021-03-16 | — | — | CN | claimed |
| EP-1937697-B1 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2013-10-16 | — | — | EP | claimed |
| US-8545946-B2 | Liquid crystal alignment solution | DAXIN MATERIALS CORPORATION (TW) | 2013-10-01 | — | — | US | claimed |
| WO-2013043321-A1 | POLYMER COMPOSITION AND METHOD | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-03-28 | — | — | WO | claimed |
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | GENERAL ELECTRIC COMPANY | 2006-12-07 | — | — | US | claimed |
| WO-2006113182-A2 | PROCESS FOR MAKING SILYLISOCYANURATE | GENERAL ELECTRIC COMPANY (US) | 2006-10-26 | — | — | WO | claimed |
| US-20060235221-A1 | Process for making silylisocyanurate | MOMENTIVE PERFORMANCE MATERIALS INC. | 2006-10-19 | — | — | US | claimed |
| US-7060849-B1 | Method for production of isocyanatosilanes | GENERAL ELECTRIC COMPANY (US) | 2006-06-13 | — | — | US | claimed |
| EP-0668326-B1 | Covalently-nucleophilic self-curing systems | FRAUNHOFER GES FORSCHUNG (DE) | 2004-07-28 | — | — | EP | claimed |
| US-6673954-B1 | REACTING AN AMINOORGANOSILANE WITH AN ORGANOCARBONATE ESTER, BASIC CATALYST | GENERAL ELECTRIC COMPANY | 2004-01-06 | — | — | US | claimed |
| US-5919885-A | Covalently and nucleophilically self-curing systems | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1999-07-06 | — | — | US | claimed |
| US-5674964-A | Self-curing systems | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1997-10-07 | — | — | US | claimed |
| EP-0668326-A2 | Covalently-nucleophilic self-curing systems | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1995-08-23 | — | — | EP | claimed |
| EP-0618242-A2 | Self-curing systems | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1994-10-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060235221-A1 | Process for making silylisocyanurate | PCMT1, SRM, STOM | ACHE 1265/4885HDAC3 15/4885HDAC4 191/4885 |
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | SI, TST, PCMT1 | ACHE 1637/4885HDAC3 99/4885HDAC4 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.